Upstream-downstream: CD28 co-signaling pathways and T cell function

Immunity

Volumn 4, Issue 6, 1996, Pages 527-534

  Rudd, Christopher E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN;

CELL FUNCTION; HUMAN; IMMUNE RESPONSE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0030176384     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80479-3     Document Type: Review

References (70)

1. August, A., and DuPont, B. (1994a). CD28 of T lymphocytes associates with phosphatidylinositol 3-kinase. Int. Immunol. 6, 769-774.
2. August, A., and DuPont, B. (1994b). Activation of the src kinase lck following CD28 crosslinking in the Jurkat leukemic cell line. Biochem. Biophys. Res. Commun. 199, 1466-1473.
3. August, A., Gibson, S., Kawakami, Y., Kawakami, T., Mills, G.B., and Dupont, B. (1994). CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T cell line. Proc. Natl. Acad. Sci. USA 91, 9347-9351.
4. Baldari, C.T., Heguy, A., and Telford, J.L. (1993). Ras protein activity is essential for T cell receptor signal transduction. J. Biol. Chem. 268, 2693-2698.
5. Berra, E., Diaz-Meco, M.T., Lozano, J., Frutos, S., Municio, M.M., Sanchez, P., Sanz, L., and Moscat, J. (1995). Evidence for a role of MEK and MAPK during signal transduction by protein kinase Cζ. EMBO J. 14, 6157-6163.
6. Blenis, J. (1993). Signal transduction via the MAP kinases: proceed at your own risk. Proc. Natl. Acad. Sci. USA 90, 5889-5892.
7. Bluestone, J. (1995). New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2, 555-559.
8. L. Immunity 3, 87-98.
9. Boucher, L.M., Wiegmann, K., Futterer, A., Pfeffer, K., Machleidt, T., Schutze, S., Mak, T.W., and Kronke, M. (1995). CD28 signals through acidic sphingomyelinase. J. Exp. Med. 181, 2059-2068.
10. Bryan, R.G., Li, Y., Lai, J.L.H., Van, M., Rice, N.R., Rich, R.R., and Tan, T.-H. (1994). The effect of CD28 signal transduction on c-Rel in human peripheral blood T cells. Mol. Cell. Biol. 14, 7933-7942.
11. Cai, Y.-C., Céfai, D., Schneider, H., Raab, M., Nabavi, N., and Rudd, C.E. (1995). Selective CD28 pYMNM mutations implicate phosphatidylinositol 3-kinase in CD28 mediated costimulation. Immunity 3, 417-426.
12. Céfai, D., Cai, Y.-C., Hu, H., and Rudd, C.E. (1996). CD28 co-stimulatory regimes differ in their dependence on PI 3-kinase: common cosignals induced by CD80 and CD86. Int. Immunol., in press.
13. Chan, G., and Ochi, A. (1995). Sphingomyelin-ceramide turnover in CD28 costimulatory signaling. Eur. J. Immunol. 25, 1999-2004.
14. Chatta, G.S., Spies, A.G., Chang, S., Mize, G.J., Linsley, P.S., Ledbetter, J.A., and Morris, D.R. (1994). Differential regulation of protooncogenes c-jun and c-fos in T lymphocytes activated through CD28. J. Immunol. 153, 5393-5401.
15. Chen, L., Ashe, S., Brady, W.A., Hellstroem, I., Hellstroem, K.E., Ledbetter, J.A., McGowan, P., and Linsley, P.S. (1992). Costimulation of antitumor immunity by the B7 counter-receptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71, 1093-1102.
16. Crew, C.M., and Erickson, R.L. (1993). Extracellular signals and reversible protein phosphorylation: what to Mek of it all. Cell 74, 215-217.
17. Crooks, M.E.C., Littman, D.R., Carter, R.H., Fearon, C.T., Weiss, A., and Stein, P.H. (1995). CD28-mediated co-stimulation in the absence of phosphatidylinositol 3-kinase association and activation. Mol. Cell. Biol. 15, 6820-6828.
18. Fantl, W.J., Escobedo, J.A., Martin, G.A., Turck, C.W., del Rosario, M., McCormick, F., and Williams, L.T. (1992). Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways. Cell 69, 413-423.
19. + T cells. Science 271, 1276-1278.
20. Franke, T.F., Yang, S-I., Chan, T.O., Datta, K., Kazlauskas, A., Morrison, D.K., Kaplan, D.R., and Tsichlis, P.N. (1995). The protein kinase encoded by the Akt protooncogene is a target of PDGF-activated phosphatidylinositol 3-kinase. Cell 81, 727-736.
21. Fraser, J.D., Irving, B.A., Crabtree, G.R., and Weiss, A. (1991). Regulation of interleukin-2 enhancer activity by the T cell accessory molecule CD28. Science 251, 313-316.
22. Freeman, G.J., Boussiotis, V.A., Anumanthan, A., Bernstein, G.M., Ke, X.-Y., Rennert, P.D., Gray, G.S., Gribben, J.G. and Nadler, L.M. (1995). B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2, 523-532.
23. Genot, E.M., Parker, P.J., and Cantrell, D.A. (1995). Analysis of the role of protein kinase C-α, -∈ and -ζ in T cell activation. J. Biol. Chem. 270, 9833-9839.
24. Ghiotto-Ragueneau, M., Battifora, M., Truneh, A., Waterfield, M.D., and Olive, D. (1996). Comparision of CD28-B7.1 and B7.2 functional interaction in resting human T cells: phosphotidylinositol 3-kinase association to CD28 and cytokine production. Eur. J. Immunol. 26, 34-41.
25. Hu, Q., Klippel, A., Muslin, A.J., Fantl, W.J., and Williams, L.T. (1995). Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science 268, 100-102.
26. Hutchcroft, J.E., and Bierer, B.E. (1994). Activation-dependent phosphorylation of the T-lymphocytes surface receptor CD28 and associated proteins. Proc. Natl. Acad. Sci. USA 91, 3260-3264.
27. Hutchcroft, J.E., Franklin, D.P., Tsai, B., Harrison-Findik, D., Varto7 covski, L., and Bierer, B. (1995). Phorbol ester treatment inhibits phosphatidylinositol 3-kinase activation by, and association with, CD28, a T-lymphocyte surface receptor. Proc. Natl. Acad. Sci. USA 92, 8808-8888.
28. Jenkins, M.K. (1994). The ups and downs of T cell costimulation. Immunity 1, 443-448.
29. June, C.H., Bluestone, J.A., Nadler, L.M., and Thompson, C.B. (1994). The B7 and CD28 receptor families. Immunol. Today 15, 321-331.
30. Kang, S.-M., Beverley, B., Tran, A.-C., Brorson, K., Schwartz, R., and Lenardo, M.J. (1992). Transactivation by AP-1 is a molecular target of T cell clonal anergy. Science 257, 1134-1138.
31. Kapeller, R., and Cantley, L.C. (1994). Phosphatidylinositol 3-kinase. BioEssays 16, 565-576.
32. Kuchroo, V.K., Das, M.P., Brown, J.A., Ranger, A.M., Zamvil, S.S., Sobel, R.A., Weiner, H.L., Nabavi, N., and Glimcher, L.H. (1995). B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80, 707-718.
33. Kyriakis, J.M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E.A., Ahmad, M.F., and Woodgett, J.R. (1994). The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369, 156-160.
34. Lai, J.-H., and Tan, T.-H. (1994). CD28 signaling caused a sustained down-regulation of IκBα which can be prevented by the immunosup7 pressant rapamcin. J. Biol Chem. 269, 30077-30080.
35. Lai, J.H., Horvath, G., Subleski, J., Bruder, J. Ghosh, P. and Tan, T.-H. (1995). Rel A is a potent transcriptional activator of the CD28 response element with the interleukin 2 promoter. Mol. Cell. Biol. 15, 4260-4271.
36. + T cells. Science 271, 1272-1275.
37. Liao, X.C., and Littman, D.R. (1995). Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk. Immunity 3, 757-769.
38. Linsley, P.S. (1995). Distinct roles for CD28 and cyotoxic T lymphocyte-associated molecule-4 receptor during T-cell activation. J. Exp. Med. 182, 459-465.
39. 2+-independent costimulatory activity Eur. J. Immunol. 24, 2732.
40. Lu, Y., Phillips, C.A., and Trevillyan, J.M. (1995). Phosphatidylinositol 3-kinase activity is not essential for CD28 costimulatory activity in Jurkat T cells: studies with a selective inhibitor, wortmannin. Eur. J. Immunol. 25, 533-537.
41. Nakanishi, H., Brewer, K.A., and Exton, J.H. (1993). Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-triphosphate. J. Biol. Chem. 268, 13-16.
42. ras. J. Exp. Med. 180, 1067-1076.
43. Pages, F., Ragueneau, M., Rottapel, R., Truneh, A., Nunes, J., Imbert, J., and Olive, D. (1994). Binding of phosphatidyl-3-OH kinase to CD28 is required for T cell signaling. Nature 369, 327-329.
44. Pai, S.-Y., Calvo, V., Wood, M., and Bierer, B.E. (1994). Crosslinking CD28 leads to activation of 70-kDa S6 kinase. Eur. J. Immunol. 24, 2364-2368.
45. Prasad, K.V.S., Cai, Y.-C., Raab, M., Duckworth, B., Cantley, L., Shoelson, S.E., and Rudd, C.E. (1994). T cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif. Proc. Natl. Acad. Sci. USA 91, 2834-2838.
46. fyn regulate CD28 recruitment of phosphatidylinositol 3 kinase, growth factor receptor-bound GRB-2 and T cell-specific protein-tyrosine kinase ITK: implications for co-stimulation. Proc. Natl. Acad. Sci. USA 92, 8891-8895.
47. ras mediates control of the IL-2 promoter function in T cell activation. EMBO J. 11, 4549-4556.
48. Rincon, M., and Flavell, R.A. (1994). AP-1 transcriptional activity requires both T cell receptor-mediated and co-stimulatory signals in primary T lymphocytes. EMBO J. 13, 4370-4381.
49. Rodriguez-Viciana, P., Warne, P.H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M.J., Waterfield, M.D., and Downward, J. (1994). Phosphatidyl-3-OH kinase as a direct target of Ras. Nature 370, 527-532.
50. Rooney, J.W., Sun, Y.-L., Glimscher, L.H., and Hoey, T. (1995). Novel NF-AT sites that mediate activation of the interleukin 2 promoter in response to T cell receptor stimulation. Mol. Cell. Biol. 15, 6299-6310.
51. Rudd, C.E., Janssen, O., Cai, Y.-C., da Silva, A.J., Raab, M., and Prasad, K.V.S. (1994). Two-step TCRζ/CD3 and CD28 signaling in T cells: SH2/SH3 domains, protein-tyrosine and lipid kinases. Immunol. Today 15, 225-234.
52. ras. Eur. J. Immunol. 25, 1044-1050.
53. Shahinian, A., Pfeffer, K., Lee, K.P., Kuendig, T.M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P.S., Thompson, C.B., and Mak, T.W. (1993). Differential T cell costimulatory requirements in CD28-deficient mice. Science 261, 609-612.
54. Songyang, Z., Shoelson, S.E., Chandhuri, M., Gish, G., Pawson, T., Haser, W.G., King, F., Roberts, T., Ratnofsky, S., Lechleider, R.J., Neel, B.G., Birge, R.B., Fajardo, J.E., Chou, M.M., Hanafusa, H., Schaffhausen, B., and Cantley, L.C. (1993). SH2 domains recognize specific phosphopeptide sequences. Cell 72, 767-778.
55. Su, B., Jacinto, E., Hibi, M., Kallunki, T., Karin, M., and Ben-Neriah, Y. (1994). JNK is involved in signal integration during costimulation of T lymphocytes. Cell 77, 727-736.
56. Thompson, C.B. (1995). Distinct roles for the costimulatory liagnds B7-1 and B7-2 in T helper cell differentiation? Cell 81, 979-982.
57. Tivol, E.A., Borriello, F., Schweitzer, A.N., Lynch, W.P., Bluestone, J.A., and Sharpe, A.H. (1995). Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541-547.
58. + T cells by B7-transfected melanoma cells. Science 259, 368-370.
59. Truitt, K.E., Hicks, C.M., and Imboden, J.B. (1994). Stimulation of CD28 triggers an association between CD28 and phosphatidylinositol-3-kinase in Jurkat T cells. J. Exp. Med. 179, 1071-1076.
60. Truitt, K.E., Shi, J., Gibson, S., Segal, L.G., Mills, G.B., and Imboden, J.B. (1995). CD28 delivers costimulatory signals independently of its association with phosphatidylinositol 3-kinase. J. Immunol. 155, 4702-4710.
61. Ueda, Y., Levine, B.L., Huang, M.L., Freeman, G.J., Nadler, L.M., June, C., and Ward, S.G. (1995). Both CD28 ligands CD80 (B7-1)and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion. Int. Immunol. 7, 957-966.
62. Walunas, T.L., Lenschow, D.J., Bakker, C.Y., Linsley, P.S., Freeman, G.J., Green, J.M., Thompson, C.B., and Bluestone, J.A. (1994). CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405-413.
63. Wang, J., Auger, K.R., Jarvis, L., Shi, Y., and Roberts, T.M. (1995). Direct association of GRb2 with the p85 subunit of phosphatidylinositol 3-kinase. J. Biol. Chem. 270, 12774-12780.
64. Ward, S.G., Westwick, J., Hall, N.D., and Sansom, D.M. (1993). Ligation of CD28 receptor by B7 induces formation of D-3phosphoinositides in T lymphocytes independently of T cell receptor/CD3 activation. Eur. J. Immunol. 23, 2572-2577.
65. Ward, S.G., Wilson, A., Turner, L., Westwick, J., and Sansom, D.M. (1995). Inhibition of CD28-mediated T cell costimulation by the phosphoinositides 3-kinase inhibitor wortmannin. Eur. J. Immunol. 25, 526-532.
66. Waterhouse, P., Penninger, J.M., Timms, E., Wakeham, A., Shahinian, A., Lee, K.P., Thompson, C.B., Griesser, H., and Mak, T.W. (1995). Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270, 985-988.
67. Weiss, A., and Littman, D.R. (1994). Signal transduction by lymphocyte antigen receptors. Cell 76, 263-274.
68. Yao, Y., and Cooper, G.M. (1995). Requirement for phosphatidylinositol 3-kinase in the prevention of apoptosis by nerve growth factor. Science 267, 2003-2006.
69. Zeng, Y.S., Bagrodia, S., and Cerinone, R.A. (1994). Activation of phosphoinositide 3-kinase activity by CDC42Hs binding to p85. J. Biol. Chem. 269, 18727-18730.
70. Zett, T., Hunt, S.W., III, Mobley, J.L., Finkelstein, L.D., and Shimizu, Y. (1996). CD28-mediated upregulation of β1 integrin adhesion involves phosphatidylinositol 3-kinase. J. Immunol. 156, 883-886.